Abstract
Srivastava RN, Agrahari AK, Singh A, Chandra T, Raj S. Effectiveness of bone marrow-derived mononuclear stem cells for neurological recovery in participants with spinal cord injury: a randomized controlled trial. Asian J Transfus Sci. 2019;13(2):120-128.
Keywords
Study Type
Study Quality:
Visual Abstract
Risk of Bias:
Why Is This Study an Important Topic?
Traumatic spinal cord injuries have devasting consequences affecting individuals, caregivers and society. Current treatment options that substantially improve neurological recovery are limited. Clinical trials of new modalities treating traumatic spinal cord injuries, such as bone-marrow derived stem cells, are much needed.
What Was the Primary Clinical Question?
Does the addition of bone-marrow derived stem cells, compared to surgical stabilization or non-operative care, result in improved neurological outcomes in patients with SCI?
Study Characteristics
Results
Result 1. Mean differences in Spinal Injury Association (ASIA) Impairment Scale 1 year following injury.
Result 2. Motor and Sensory Scores (higher = better) 1 year following injury.
How Will This Affect the Care of My Patients?
Surgery should be considered over non-operative care when indicated. In addition to surgical stabilization, one bone-marrow derived stem cells should also be considered.
